Table 3.
Infectivity analysis of the bba34 mutant in C3H/HeN mice at 21 days postinfection
| Strain/dose | No. of cultures positive/no. tested |
No. of mice infected/no. tested | ||||||
|---|---|---|---|---|---|---|---|---|
| Skin | Spleen | Joint | Lymph node | Heart | Bladder | All sites | ||
| wt | ||||||||
| 102 | 3/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 17/18 | 3/3 |
| 103 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
| 104 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
| 105 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
| mt | ||||||||
| 102 | 2/3 | 0/3 | 2/3 | 2/3 | 2/3 | 2/3 | 10/18 | 2/3 |
| 103 | 3/3 | 2/3 | 2/3 | 3/3 | 3/3 | 3/3 | 16/18 | 3/3 |
| 104 | 3/3 | 2/3 | 3/3 | 2/3 | 3/3 | 3/3 | 16/18 | 3/3 |
| 105 | 3/3 | 1/3 | 3/3 | 2/3 | 3/3 | 3/3 | 15/18 | 3/3 |
| ct | ||||||||
| 102 | 2/3 | 0/3 | 2/3 | 2/3 | 2/3 | 2/3 | 10/18 | 2/3 |
| 103 | 3/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 17/18 | 3/3 |
| 104 | 3/3 | 0/3 | 3/3 | 2/3 | 3/3 | 3/3 | 14/18 | 3/3 |
| 105 | 3/3 | 0/3 | 3/3 | 3/3 | 3/3 | 3/3 | 14/18 | 3/3 |